155 related articles for article (PubMed ID: 23714524)
1. Biology and treatment of acute lymphocytic leukemia in adolescents and young adults.
Advani AS
Am Soc Clin Oncol Educ Book; 2013; ():285-9. PubMed ID: 23714524
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
Kansagra A; Litzow M
Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
[TBL] [Abstract][Full Text] [Related]
3. Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol.
Hocking J; Schwarer AP; Gasiorowski R; Patil S; Avery S; Gibson J; Iland H; Ho PJ; Joshua D; Muirhead J; Lai H; Irving I
Leuk Lymphoma; 2014 Dec; 55(12):2801-7. PubMed ID: 24528220
[TBL] [Abstract][Full Text] [Related]
4. [Acute lymphoblastic leukemia and chronic lymphocytic leukemia in adults].
Usui N
Rinsho Ketsueki; 2012 Feb; 53(2):164-75. PubMed ID: 22450575
[No Abstract] [Full Text] [Related]
5. [Biological features and therapeutic strategies of acute lymphoblastic leukemia in adolescents and young adults].
Suenobu S; Horibe K
Rinsho Ketsueki; 2012 Aug; 53(8):740-6. PubMed ID: 22975813
[No Abstract] [Full Text] [Related]
6. [Acute lymphoblastic leukemia in adolescents and young adults].
Hayakawa F
Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
[TBL] [Abstract][Full Text] [Related]
7. Management of acute lymphoblastic leukemia in young adults.
Muffly LS; Reizine N; Stock W
Clin Adv Hematol Oncol; 2018 Feb; 16(2):138-146. PubMed ID: 29741514
[TBL] [Abstract][Full Text] [Related]
8. Acute lymphoblastic leukemia in adolescents and young adults.
Rytting ME; Jabbour EJ; O'Brien SM; Kantarjian HM
Cancer; 2017 Jul; 123(13):2398-2403. PubMed ID: 28328172
[TBL] [Abstract][Full Text] [Related]
9. [Treatment strategy for childhood and adolescent acute lymphoblastic leukemia in first remission].
Hori H
Rinsho Ketsueki; 2010 Jul; 51(7):454-9. PubMed ID: 20693762
[No Abstract] [Full Text] [Related]
10. [Treatment of adult Ph-negative acute lymphoblastic leukemia].
Imai K
Rinsho Ketsueki; 2014 Oct; 55(10):1962-71. PubMed ID: 25297761
[No Abstract] [Full Text] [Related]
11. Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults.
Litzow MR
Hematology Am Soc Hematol Educ Program; 2009; ():362-70. PubMed ID: 20008222
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor.
Togasaki E; Shono K; Onoda M; Yokota A
Leuk Lymphoma; 2015 Jan; 56(1):244-7. PubMed ID: 24730539
[No Abstract] [Full Text] [Related]
13. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
[TBL] [Abstract][Full Text] [Related]
14. Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.
Fang J; Zhang R; Wang H; Hong M; Wu Q; Nie D; You Y; Zhong Z; Li W; Hu Y; Xia L
Leuk Res; 2016 Jul; 46():61-8. PubMed ID: 27131062
[TBL] [Abstract][Full Text] [Related]
15. Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults.
Friend BD; Schiller GJ
Blood Rev; 2018 Mar; 32(2):122-129. PubMed ID: 28969872
[TBL] [Abstract][Full Text] [Related]
16. Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Vignon M; Andreoli A; Dhédin N; Lengliné E; Masson E; Robin M; Granier C; Larghero J; Schlageter MH; de Latour RP; Socié G; Boissel N
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):299-306. PubMed ID: 27983886
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic stem cell transplantation for multiple myeloma.
Konishi Y; Tada K; Nishi K; Imada K
Ann Hematol; 2016 Oct; 95(10):1739-40. PubMed ID: 27473192
[No Abstract] [Full Text] [Related]
19. Should treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia be intensive? Intensive treatment is the best treatment for these patients.
Short NJ; Jabbour E
Clin Adv Hematol Oncol; 2016 Nov; 14(11):892-894. PubMed ID: 27930640
[No Abstract] [Full Text] [Related]
20. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
Fathi AT; DeAngelo DJ; Stevenson KE; Kolitz JE; Asch JD; Amrein PC; Attar EC; Steensma DP; Wadleigh M; Foster J; Connolly C; Galinsky I; Devoe CE; Stone RM; Neuberg DS; Ballen KK
Cancer; 2016 Aug; 122(15):2379-88. PubMed ID: 27171984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
